Evidence map›Paper›PMID 34093087›Full record

ArticleCrystEngComm2021

Controlled titration-based ZnO formation.

Mark M J van Rijt, Bernette M Oosterlaken, Heiner Friedrich, Gijsbertus de With

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CrystEngComm, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mark M J van RijtLaboratory of Physical Chemistry, Centre for Multiscale Electron Microscopy, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology P. O. Box 513 Eindhoven 5600 MB The Netherlands G.deWith@tue.nl.ORCID https://orcid.org/0000-0002-9134-7493
Bernette M OosterlakenLaboratory of Physical Chemistry, Centre for Multiscale Electron Microscopy, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology P. O. Box 513 Eindhoven 5600 MB The Netherlands G.deWith@tue.nl.
Heiner FriedrichLaboratory of Physical Chemistry, Centre for Multiscale Electron Microscopy, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology P. O. Box 513 Eindhoven 5600 MB The Netherlands G.deWith@tue.nl.ORCID https://orcid.org/0000-0003-4582-0064
Gijsbertus de WithLaboratory of Physical Chemistry, Centre for Multiscale Electron Microscopy, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology P. O. Box 513 Eindhoven 5600 MB The Netherlands G.deWith@tue.nl.ORCID https://orcid.org/0000-0002-7163-8429
Eindhoven University of Technology · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hexamethylenetetramine (HMTA) is commonly used as a base releasing agent for the synthesis of ZnO under mild aqueous conditions. HMTA hydrolysis leads to gradual formation of a base during the reaction. Use of HMTA, however, does have limitations: HMTA hydrolysis yields both formaldehyde and ammonia, it provides no direct control over the ammonia addition rate or the total amount of ammonia added during the reaction, it results in a limited applicable pH range and it dictates the accessible reaction temperatures. To overcome these restrictions, this work presents a direct base titration strategy for ZnO synthesis in which a continuous base addition rate is maintained. Using this highly flexible strategy, wurtzite ZnO can be synthesized at a pH >5.5 using either KOH or ammonia as a base source at various addition rates and reaction pH values.

Identifiers

PMID34093087
PMCPMC8107948
OpenAlexW3138767768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.